Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

Loomba, R; Sanyal, AJ; Kowdley, KV; Bhatt, DL; Alkhouri, N; Frias, JP; Bedossa, P; Harrison, SA; Lazas, D; Barish, R; Gottwald, MD; Feng, SB; Agollah, GD; Hartsfield, CL; Mansbach, H; Margalit, M; Abdelmalek, MF

Loomba, R (通讯作者),Univ Calif San Diego, NAFLD Res Ctr, Dept Med, Div Gastroenterol & Hepatol, La Jolla, CA 92037 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2023; 389 (11): 998

Abstract

BACKGROUND Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FG......

Full Text Link